Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects
Clinical trial NCT07166081 · RECRUITING
Trial details
- NCT number
- NCT07166081
- Sponsor
- BrightGene Bio-Medical Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-11
- Primary completion
- 2026-01-12
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.